Tower Research Capital LLC (Trc) Biofrontera Inc. Transaction History

Tower Research Capital LLC (Trc)

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$0.4 - $0.65 $48 - $79	-122 Reduced 0.92%	13,109 $6,000
Q1 2023 May 09, 2023	BUY	$0.56 - $1.02 $5,035 - $9,171	8,992 Added 212.13%	13,231 $8,000
Q4 2022 Feb 10, 2023	SELL	$0.77 - $24.8 $3,411 - $109,864	-4,430 Reduced 51.1%	4,239 $4,000
Q3 2022 Nov 10, 2022	BUY	$0.82 - $41.8 $7,108 - $362,364	8,669 New	8,669 $9,000
Q1 2022 May 12, 2022	SELL	$45.0 - $138.4 $7,110 - $21,867	-158 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$49.4 - $263.4 $7,805 - $41,617	158 New	158 $1,000

Ticker BFRI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 23,551,000
Market Cap $30.1M
Description
Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company offers Ameluz, which is a prescription drug approved for use in combination with the company's licensor's medical device; and the RhodoLED lamp series for phot...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.